Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy program
Florent Charra(Hospices Civils de Lyon), Florence Ranchon(Lyon 1 Université), Vérane Schwiertz(Hospices Civils de Lyon), Virginie Larbre(Lyon 1 Université), Fiorenza Barraco(Hôpital Lyon Sud), Catherine Rioufol(Lyon 1 Université), Chloé Herledan(Lyon 1 Université), Nicolas Vantard(Hospices Civils de Lyon), Hélène Labussière‐Wallet(Hospices Civils de Lyon), Gilles Salles(Memorial Sloan Kettering Cancer Center), Michaël Philippe(Hospices Civils de Lyon), Sophie Ducastelle-Leprêtre(Hospices Civils de Lyon), Marie Larcher(Hospices Civils de Lyon), Anne-Gaëlle Caffin(Hospices Civils de Lyon), Amandine Baudouin, Marie Balsat(Hôpital Claude Huriez)
Cited by 10
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
|Advances in Therapy|2017|603